MIP and tuberculosis: In a large scale double blind trial for immunoprophylaxis against leprosy, involving 28,948 people in 272 villages of Ghatampur, Kanpur, India, a retrospective analysis after 13 years showed that incidence of TB was significantly reduced in the healthy contacts of leprosy patients vaccinated with MIP as compared to the placebo group11.